Gene · 7439
Papers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Best vitelliform macular dystrophy caused by a BEST1 p.(Ser246Asn) variant coexisting with diabetic retinopathy. | Doc Ophthalmol | 2026 | 41051727 | PubTator, text mining | PubMed |
| IDIOPATHIC ACUTE EXUDATIVE POLYMORPHOUS VITELLIFORM MACULOPATHY-CASE SERIES AND EXTENDED FEATURES. | Retin Cases Brief Rep | 2026 | 40712134 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| Precision therapeutic tRNA rescue of nonsense mutation R166X in KCNJ13 to restore K+ channel function. | J Precis Med (Amst) | 2025 | 42415716 | PubTator, text mining | PubMed |
| Intracellular Chloride Channels: A Rising Target in Lung Disease Research. | J Respir Biol Transl Med | 2025 | 41907764 | PubTator, text mining | PubMed |
| Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation. | Cell Death Discov | 2025 | 41249152 | PubTator, text mining | PubMed |
| Axial Length Profiles in Inherited Retinal Diseases-A Genotypic and Phenotypic Analysis. | Invest Ophthalmol Vis Sci | 2025 | 41117592 | PubTator, text mining | PubMed |
| Gene Therapy Strategies for the Treatment of Bestrophinopathies. | Int J Mol Sci | 2025 | 41096689 | PubTator, text mining | PubMed |
| Corrigendum to "Generation of the induced pluripotent stem cell line SJTUGHi004-A derived from a Best's disease patient with c.763C > T mutation in BEST1 gene" [Stem Cell Res. 88 (2025) 103806]. | Stem Cell Res | 2025 | 41033190 | PubTator, text mining | PubMed |
| RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals. | Invest Ophthalmol Vis Sci | 2025 | 40985799 | PubTator, text mining | PubMed |
| Novel BEST1 Variant Characterization in a Large French Cohort in Light of Updated Bestrophin-1 Structure-Function Correlation. | Invest Ophthalmol Vis Sci | 2025 | 40891781 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| Generation of the induced pluripotent stem cell line SJTUGHi004-A derived from a Best's disease patient with c.763C > T mutation in BEST1 gene. | Stem Cell Res | 2025 | 40848399 | PubTator, text mining | PubMed |
| Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy. | Genes Dis | 2025 | 40808876 | PubTator, text mining | PubMed |
| Best Vitelliform Macular Dystrophy. | Adv Exp Med Biol | 2025 | 40736831 | PubTator, text mining | PubMed |
| Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders. | Int J Mol Sci | 2025 | 40724865 | PubTator, text mining | PubMed |
| Clinical and Genetic Features of Autosomal Recessive Bestrophinopathy: A Case Series from a Vietnamese Cohort. | Biomedicines | 2025 | 40722697 | PubTator, text mining | PubMed |
| Acoustic technologies for the orchestration of cellular functions for therapeutic applications. | Sci Adv | 2025 | 40680134 | PubTator, text mining | PubMed |
| Porcine Single-Eye Retinal Pigment Epithelium Cell Culture for Barrier and Polarity Studies. | Cells | 2025 | 40643526 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals BEST1 as a potential tumor-associated gene in gliomas. | Neuroscience | 2025 | 40614923 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7439/papers?page=3